MICHAELA PASCHAL: Open Payments
NPI 1750020129 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 11 payments from 6 companies in 2025. Trend: 2023 $457 · 2024 $240 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| PFIZER INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: XIFAXAN, TRELEGY ELLIPTA, GVOKE HYPOPEN, CAMZYOS, SHINGRIX, COMIRNATY, VOQUEZNA, ELIQUIS.
Industry payments across TN — which companies pay providers there.
